lobbying_activities: 2954246

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2954246	da7482bf-a22f-45da-a22c-069b85f2b3b0	Q1	STONINGTON GLOBAL	401105189	SORRENTO THERAPEUTICS, INC.	2023	first_quarter	PHA	Promoting non-opioid pain management alternatives.	Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	60000		0	0	2023-03-27T11:04:21-04:00